Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-20

Clinical Trial Update: Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine [Phase 4]

View source ↗

Summary

Phase 4 trial update on the Tx360 Nasal Applicator for chronic migraine; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tx360 Nasal Applicator

Snippet

Sponsor: Tian Medical Inc. | Conditions: Chronic Migraine | Phase 4 | Status: COMPLETED | Results posted: 2014-10-20